To examine the anti‐tumour role of SPOP on NSCLC, we silenced endogenous SPOP via siRNA and found that knockdown of SPOP promoted A549 cell proliferation, whereas overexpression of SPOP inhibited cell proliferation (Figure 3G). The gene discussed is SPOP; the disease is neoplasm.